NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities
NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities - Biometric based digital signature without storing a patient's facial information and tampering detection technology with minimal validation data - TOKYO, Apr 1, 2025 - (JCN Newswire) - NEC Corporation (NEC; TSE:…
bubmagApril 1, 2025